Hongo et al., 1995 - Google Patents
Development and characterization of murine monoclonal antibodies to the latency-associated peptide of transforming growth factor β1Hongo et al., 1995
- Document ID
- 1604318995487891921
- Author
- Hongo J
- MORA-WORMS M
- LUCAS C
- FENDLY B
- Publication year
- Publication venue
- Hybridoma
External Links
Snippet
Transforming growth factor β (TGF-β) is a multifunctional peptide that controls proliferation, differentiation, and other functions in a variety of cell types. Transforming growth factor β activities have been implicated in a variety of diseased states including arthritis, prostate …
- 102400000401 Latency-associated peptide 0 title abstract description 111
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hongo et al. | Development and characterization of murine monoclonal antibodies to the latency-associated peptide of transforming growth factor β1 | |
| Dasch et al. | Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. | |
| US5783185A (en) | Monoclonal antibodies to transforming growth factor-beta and methods of use | |
| EP0267611B1 (en) | Antibody against interleukin-1 | |
| Vidal et al. | Alternative mechanism of protein A-immunoglobulin interaction the VH-associated reactivity of a monoclonal human IgM. | |
| Kasahara et al. | Preparation and characterization of polyclonal and monoclonal antibodies against human interleukin 1 alpha (IL 1 alpha). | |
| Kemeny et al. | Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissue and pathologic human kidney biopsies | |
| EP0605410B1 (en) | Immunodiagnostic assay for rheumatoid arthritis | |
| DK168872B1 (en) | Method for producing antibodies for immunological determination of amino-terminal procollagen peptide (type III) and / or procollagen (type III), antibodies produced by the method, use of the antibodies for immunological determination of amino-terminal procollagen peptide (type III) and / or procollagen (type III) and starting product for use in the process | |
| CA2058041A1 (en) | Anti-igf-ii monoclonal antibody | |
| Nakamura et al. | Characterization of monoclonal nonspecific suppressor factor (MNSF) with the use of a monoclonal antibody. | |
| JPH04293496A (en) | Monoclonal antibody | |
| US5679583A (en) | Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids | |
| BAETS et al. | Monoclonal antibodies to human thyroglobulin as probes for thyroglobulin structure | |
| JP2955082B2 (en) | Monoclonal antibody that specifically recognizes the N-terminal part of human calcitonin | |
| EP0345811B1 (en) | Monoclonal abtibodies specific for human fibrinopeptide A | |
| Jaafar et al. | Immunogenic and antigenic epitopes of immunoglobulins—V. Reactivity of a panel of monoclonal antibodies with sub-fragments of human Fcγ and abnormal paraproteins having deletions | |
| IE63371B1 (en) | Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (Type III) and procollagen (Type III) in body fluids | |
| Dasch et al. | Characterization of monoclonal antibodies recognizing bovine bone osteoglycin | |
| Liang et al. | Study of antigenic epitopes recognized by monoclonal antibodies to recombinant interferon-gamma | |
| Scott et al. | Monoclonal antibodies specific for non-glycosylated porcine prolactin and for pituitary porcine prolactin | |
| JPH07258298A (en) | Monoclonal antibody | |
| JP2613067B2 (en) | Monoclonal antibodies and methods of use | |
| Chuang et al. | Preparation and characterization of monoclonal antibody specific for α-bungarotoxin and localization of the epitope | |
| Kittelberger-Ewert et al. | Production and specificity of antibodies against the central region of type II collagen |